Resiliency and Relentlessness are Crucial for Raising Medtech Capital: Interview with Beverly Huss, President and CEO of Qool Therapeutics episode artwork

EPISODE · Apr 24, 2020 · 49 MIN

Resiliency and Relentlessness are Crucial for Raising Medtech Capital: Interview with Beverly Huss, President and CEO of Qool Therapeutics

from Medsider: Learn from Medtech and Healthtech Founders and CEOs · host Scott Nelson

Joining us for this episode is Beverly Huss, President and CEO of Qool Therapeutics, a development-stage company working on a novel, non-invasive therapeutic hypothermia device for the preservation of tissue following catastrophic events like a heart a...

Episode metadata supplied by the publisher feed · Published Apr 24, 2020

Embed this episode

Ready to play

Resiliency and Relentlessness are Crucial for Raising Medtech Capital: Interview with Beverly Huss, President and CEO of Qool Therapeutics

0:00 49:16

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medsider: Learn from Medtech and Healthtech Founders and CEOs?

This episode is 49 minutes long.

When was this Medsider: Learn from Medtech and Healthtech Founders and CEOs episode published?

This episode was published on April 24, 2020.

Can I download this Medsider: Learn from Medtech and Healthtech Founders and CEOs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!